A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

Rotavirus is the most common cause of moderate-to-severe infant diarrhoea in developing countries, resulting in enormous morbidity, mortality, and economic burden. A bovine-human reassortant pentavalent rotavirus vaccine (BRV-PV) targeting the globally most common strains was developed in India and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine
Hauptverfasser: Kulkarni, Prasad S., Desai, Sajjad, Tewari, Tushar, Kawade, Anand, Goyal, Nidhi, Garg, Bishan Swarup, Kumar, Dinesh, Kanungo, Suman, Kamat, Veena, Kang, Gagandeep, Bavdekar, Ashish, Babji, Sudhir, Juvekar, Sanjay, Manna, Byomkesh, Dutta, Shanta, Angurana, Rama, Dewan, Deepika, Dharmadhikari, Abhijeet, Zade, Jagdish K., Dhere, Rajeev M., Fix, Alan, Power, Maureen, Uprety, Vidyasagar, Parulekar, Varsha, Cho, Iksung, Chandola, Temsunaro R., Kedia, Vikash K., Raut, Abhishek, Flores, Jorge
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier Science 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651219/
https://ncbi.nlm.nih.gov/pubmed/28967523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.09.014
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge